| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |